Jump to Content Jump to Main Navigation
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues Themed Collections
Submit now Author guidelines Reasons to publish Ethical policy Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Impact Factor Collection Highlights of 2021 Editor's choice Accepted manuscripts Current issue All issues Special issues Themed Collections
Submit now Author guidelines Reasons to publish Ethical policy Open-access policy Publication charges Author resource centre
Contact the journal Scope Editorial board Societies For libraries Subscribe Abstracting and indexing
Alerts Journals
Advanced Search Help

Volume 28 (2021): Issue 10 (Oct 2021)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the buttons to receive email notifications of the latest research.

  • Sign up for new article alerts
  • Sign up for eTOC alerts
  • Get Accepted Manuscript Alerts
  • Editorial
    • Radioiodine: 80 years and counting; the past, present, and future
  • Thematic Review
    • Radioiodine treatment: an historical and future perspective
    • Tailoring the approach to radioactive iodine treatment in thyroid cancer
    • The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues
    • Na+/I− symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy
    • Redifferentiation-facilitated radioiodine therapy in thyroid cancer
    • The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment
  • Research
    • Development of improved SRC-3 inhibitors as breast cancer therapeutic agents
    • Targeted genomic analysis of 364 adrenocortical carcinomas
    • Antitumor immune response is associated with favorable survival in GEP-NEN G3
  • Save
  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821
  • Accessibility
  • Sales & advertising
  • Publishing alliances
  • Privacy & cookies
  • Terms and conditions
  • Permissions
  • Help

© 2023 Bioscientifica Ltd

Follow us on: Share Share

Print ISSN: 1351-0088; Online ISSN: 1479-6821    Powered by:

PubFactory
  • [3.238.250.73]
  • 3.238.250.73
Close
Edit

Character limit 500/500

@!

Character limit 500/500